Inibidores da HIV-integrase: Potencial abordagem farmacológica para tratamento da AIDS

dc.contributorUniversidade Estadual Paulista (UNESP)
dc.creatorDe Melo, Eduardo Borges
dc.creatorBruni, Aline Thaís
dc.creatorCastro Ferreira, Márcia Miguel
dc.date2014-05-27T11:21:53Z
dc.date2016-10-25T18:22:18Z
dc.date2014-05-27T11:21:53Z
dc.date2016-10-25T18:22:18Z
dc.date2006-06-23
dc.date.accessioned2017-04-06T01:19:05Z
dc.date.available2017-04-06T01:19:05Z
dc.identifierQuimica Nova, v. 29, n. 3, p. 555-562, 2006.
dc.identifier0100-4042
dc.identifierhttp://hdl.handle.net/11449/68928
dc.identifierhttp://acervodigital.unesp.br/handle/11449/68928
dc.identifier10.1590/S0100-40422006000300026
dc.identifierS0100-40422006000300026
dc.identifierWOS:000237772900026
dc.identifier2-s2.0-33745180535.pdf
dc.identifier2-s2.0-33745180535
dc.identifierhttp://dx.doi.org/10.1590/S0100-40422006000300026
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/890234
dc.descriptionAIDS has the HIV as its etiological agent. Researches has been done to find new pharmacological agents to be used in therapy, because of problems of resistance and side effects. The HIV-integrase inhibitors are some of those new agents that are being studied. This updating focusses on the fundamental information about HIV and HIV-integrase and the main methods being used to develop these new drugs, with examples for each case.
dc.languagepor
dc.relationQuímica Nova
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAIDS
dc.subjectHIV
dc.subjectIntegrase
dc.titleInibidores da HIV-integrase: Potencial abordagem farmacológica para tratamento da AIDS
dc.typeOtro


Este ítem pertenece a la siguiente institución